Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04517929
Other study ID # 20-6.1T/49
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 20, 2020
Est. completion date April 1, 2022

Study information

Verified date January 2023
Source Ege University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The hypothesis of the study is that group therapy in fibromyalgia patients can provide significant improvement in pain, fatigue, anxiety and depression levels and emotional expressions.


Description:

The purpose of our study; to determine the effectiveness of group psychotherapy in the treatment of Fibromyalgia Syndrome. Patients who received 9 weeks of group therapy and those who did not, at the beginning of treatment, at the end of 9 weeks and 6 months after treatment will be evaluated using The Short Form-36, Fibromyalgia Impact Questionnaire, Revised Fibromyalgia Impact Questionnaire, Hospital Anxiety and Depression Scale, Fatigue Severity Scale, Beck Depression Inventory, Beck Anxiety Inventory, Pain Beliefs Scale, Emotional Expression Questionnaire, Visual Analogue Scale, Childhood Trauma Questionnaire, 2016 Fibromyalgia Diagnostic Criteria. At the end of the study, individuals are expected to show less depressive symptoms and anxiety symptoms compared to the beginning of the study, and it is thought that their complaints about pain will decrease.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date April 1, 2022
Est. primary completion date January 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Fibromyalgia Syndrome diagnosed according to 2016 Fibromyalgia Syndrome diagnostic criteria - Volunteers between the ages of 18-65 - Literate volunteers - Volunteering to participate in group work - There is no obstacle to attend the sessions regularly every week Exclusion Criteria: - Who cannot participate in 9-week group therapy - Under 18, over 65 years old - Confused enough to not be able to complete and understand the scales given cognitively - Having serious mental illness (eg Psychotic disorder, Mental Retardation etc.) - Illiterate individuals

Study Design


Intervention

Other:
Group Psychotherapy
9 week group psychotherapy, given by a psychologist trained in group psychotherapy.

Locations

Country Name City State
Turkey Ege University Faculty of Medicine Izmir

Sponsors (1)

Lead Sponsor Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

References & Publications (12)

Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006 Aug;67(8):1219-25. doi: 10.4088/jcp.v67n0807. — View Citation

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available. — View Citation

BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004. No abstract available. — View Citation

Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007 Mar 9;8:27. doi: 10.1186/1471-2474-8-27. — View Citation

Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, Sapareto E, Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994 Aug;151(8):1132-6. doi: 10.1176/ajp.151.8.1132. — View Citation

Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Zule W. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003 Feb;27(2):169-90. doi: 10.1016/s0145-2134(02)00541-0. — View Citation

Clauw DJ, Arnold LM, McCarberg BH; FibroCollaborative. The science of fibromyalgia. Mayo Clin Proc. 2011 Sep;86(9):907-11. doi: 10.4065/mcp.2011.0206. — View Citation

Edwards LC, Pearce SA, Turner-Stokes L, Jones A. The Pain Beliefs Questionnaire: an investigation of beliefs in the causes and consequences of pain. Pain. 1992 Dec;51(3):267-272. doi: 10.1016/0304-3959(92)90209-T. — View Citation

Hisli N. Beck Depresyon Ölçegi'nin bir Türk örnekleminde geçerlik ve güvenirligi. Psikoloji Dergisi 1988; 6:118-122.

Jones GT, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015 Feb;67(2):568-75. doi: 10.1002/art.38905. — View Citation

Kuzucu Y. , "Duygulari Ifade Etme Ölçegi'nin Uyarlanmasi: Geçerlik Ve Güvenirlik Çalismalari" Kastamonu Egitim Dergisi, Cilt:19 No:3, 2011,779-792.

Ulusoy M, Sahin NH, Erkmen H. Turkish version of the Beck Anxiety Inventory: Psychometric properties. J Cognit Psychother 1996; 12:163- 172

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Pain-Visual Analog Scale Chronic musculoskeletal pain in Fibromyalgia syndrome patients, in this scale minumum value is 0, maximum value is 10, higher scores means worse outcome. At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Primary Change in Depression-Beck Depression Inventory Depression in Fibromyalgia patients At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Primary Change in Anxiety-Beck Anxiety Inventory Anxiety in Fibromyalgia patients At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary Change in The Short Form (36) Health Survey The Short Form (36) Health Survey At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary Change in Fibromyalgia Impact Questionaire Fibromyalgia Impact Questionaire At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary Change in Revised Fibromyalgia Impact Questionnaire Revised Fibromyalgia Impact Questionnaire At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary Change in Hospital Anxiety and Depression Scale Hospital Anxiety and Depression Scale, in this scale minumum value is 0, maximum value is 21, high scores mean worse outcome. At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary Change in The Fatigue Severity Scale The Fatigue Severity Scale, In this scale consisting of 9 items, each item is scored between 1 and 7 (1 = strongly disagree, 7 = totally agree) and the total score is calculated by taking the average of 9 items, high scores mean worse outcome. At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary Change in Pain beliefs questionnaire Pain beliefs questionnaire At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary Change in Emotional Expression Questionnaire Emotional Expression Questionnaire At the beginnning of the study ,through study completion-8th week, after study completion -6th month
Secondary CHILDHOOD TRAUMA QUESTIONNAIRE CHILDHOOD TRAUMA QUESTIONNAIRE At the beginning of the study
Secondary Change in 2016 Fibromyalgia Syndrome Criteria 2016 Fibromyalgia Syndrome Criteria
2016 Fibromyalgia Diagnostic Criteria
At the beginnning of the study ,through study completion-8th week, after study completion -6th month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05933486 - Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome Phase 4
Completed NCT01642810 - Online Acceptance-based Behavioural Treatment for Fibromyalgia Phase 3
Completed NCT00757679 - Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran Phase 2
Completed NCT00757731 - FMS European Long-Term Study Phase 3
Completed NCT01968772 - Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia N/A
Completed NCT00401830 - Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome. Phase 2
Completed NCT06285045 - Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression N/A
Completed NCT03844412 - Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments Phase 2
Completed NCT02800720 - Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome N/A
Not yet recruiting NCT01465477 - Influenza Vaccination in Fibromyalgia Patients N/A
Completed NCT00528710 - Efficacy of S-Adenosylmethionine in Fibromyalgia Phase 2
Completed NCT00447083 - Benefits of Tanning in Fibromyalgia Patients N/A
Not yet recruiting NCT06147882 - The Effect of Positive Psychotherapy Based Psychoeducation on Pain Perception With Fibromyalgia Syndrome N/A
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A
Completed NCT00464737 - The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults. Phase 2
Completed NCT04426864 - Efficacy of Different Types of Exercises in Women With Fibromyalgia Syndrome. N/A
Completed NCT02881411 - Self Soft Tissue Therapy for Fibromyalgia Syndrome N/A
Completed NCT01389336 - Add-on Complex Ayurvedic Treatment in Fibromyalgia-Syndrome Compared to Standard Care Alone N/A
Not yet recruiting NCT01147263 - Palpitations and Tachycardia in Fibromyalgia Syndrome N/A
Completed NCT00222274 - HRV Biofeedback in Fibromyalgia N/A